{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:Interferon",
      "entity_text" : "IFN",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O95786",
      "entity_text" : "RIG-I",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Subsequent activation of RIG-I by this ligand has been shown to induce type I IFN production and to activate NF-kappaB, and studies employing RNA polymerase III knockdown or pharmacological inhibitors of this enzyme have shown that this pathway is important in cell responses to the gammaherpesvirus Epstein-Barr virus.",
  "reading_complete" : "2020-08-08T16:17:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T16:13:21Z",
  "trigger" : "induce",
  "evidence" : [ "RIG-I by this ligand has been shown to induce type I IFN" ],
  "pmc_id" : "3379540",
  "score" : 0
}